Breast lumps epidemiology and demographics
Breast lumps Microchapters
Breast lumps epidemiology and demographics On the Web
American Roentgen Ray Society Images of Breast lumps epidemiology and demographics
Risk calculators and risk factors for Breast lumps epidemiology and demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. ; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.
The incidence rate of breast lumps is not particularly clear due to the fact that breast lumps is not considered as a life threatening condition and majority of the women who receives medical therapies or surgeries come into account.The prevalence of benign breast disease is approximately 68% among all breast diseases and the incidence of breast diseases is higher on the left upper/outer quadrant of breast. Fibrocystic diseases are more frequent in age of 40-44 years and fibroadenoma is more frequent between 15-35 years. Fibroadenoma rate is higher in black women. African-American women have worse prognosis and higher mortality rate in comparison European American women.
Epidemiology and Demographics
- The incidence rate of benign breast disease is unclear due to the fact that breast lumps is not considered as a life threatening condition.
- Majority of the women who receives medical therapies or surgeries come into account.
- Particular detection rate is unknown and not estimated.
- The prevalence of benign breast disease is approximately 68% among all breast diseases.
- Approximately 60% of benign breast diseases occur in left breast and 40% in the right breast.
- 100% of definite palpable lumps are characteristics of fibroadenoma, phyllodes tumor, and adenomyoepithelioma.
- 64% of lumps located in upper outer quadrant, 26% of lumps in lower outer quadrant, 10% of lumps in upper inner quadrant.
Age-specific incidence rate of benign breast diseases.
- The incidence rate of fibrocystic disease is 137 per 100,000 in women aged 25-29 years, 411 per 100,000 in age of 40-44 years and 387 per 100,000 in 45-49 years.
- The incidence rate of fibroadenoma is 115 per 100,000 in women aged 20-24 years.
- The peak incidence rate of fibroadenoma is between 15-35 years.
- Fibrocystic disease, phyllodes tumor, and adenomyoepithelioma are usually seen in 3rd and 4th decade of life.
- African American women have worse prognosis and higher mortality rate in comparison to European American women.
- European American women have higher incidence rate of breast cancers.
- The prevalence of fibroadenoma is higher in black women than white individuals.
- ↑ 1.0 1.1 Goehring C, Morabia A (1997). "Epidemiology of benign breast disease, with special attention to histologic types". Epidemiol Rev. 19 (2): 310–27. PMID 9494790.
- ↑ 2.0 2.1 M, Dr. Vijayalakshmi; Rao, Dr. J Yadigiri; Shekar, Dr. T.Y.; Balakrishnan, Dr. Shobha; M, Dr. Divya; K, Dr. Sameera; N, Dr. Alekya; JVNK, Dr. Aravind (2016). "Prevalence of Benign Breast Disease and Risk of Malignancy in Benign Breast Diseases". IOSR Journal of Dental and Medical Sciences. 15 (08): 32–36. doi:10.9790/0853-1508083236. ISSN 2279-0861.
- ↑ Hughes LE, Mansel RE, Webster DJ (1987). "Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders". Lancet. 2 (8571): 1316–9. PMID 2890912.
- ↑ Gupta V, Haque I, Chakraborty J, Graff S, Banerjee S, Banerjee SK (2018). "Racial disparity in breast cancer: can it be mattered for prognosis and therapy". J Cell Commun Signal. 12 (1): 119–132. doi:10.1007/s12079-017-0416-4. PMC 5842180. PMID 29188479.
- ↑ Oluwole SF, Freeman HP (1979). "Analysis of benign breast lesions in blacks". Am J Surg. 137 (6): 786–9. PMID 453472.